INS and Hypoglycemia: In the CAROLINA trial, subjects randomized to glipizide had significantly more hypoglycemia than did those randomized to linagliptin and in UKPDS those randomized to sulfonylurea [glipizide or chlorpropamide) plus ultralente insulin had less hypoglycemia than did those randomized to ultralente insulin alone [6,7].